Symbiomix Therapeutics

Healthcare 📍 Newark, United States 👥 51-200 employees 💰 $41.0M raised 📅 Founded 2012

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women’s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepren

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

51-200

Total Raised · Venture

$41.0M

Founded

2012

Cloud

Unknown

Email

Mimecast

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Mimecast
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$450K – $1M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Symbiomix Therapeutics's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Mylan Specialty

201-500 ☁️ AWS

201-500 ☁️ Cloudflare

Park Hotels & Resorts

51-200 ☁️ Unknown

Data detected 2026-06-13 · Methodology · Suggest a correction